Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable (Details Narrative)

v3.23.3
Accounts Payable (Details Narrative) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Research and Development Expense $ 1,364 $ 2,743 $ 5,109 $ 5,969  
Stock Issued During Period, Value, New Issues     6,268    
Accounts Payable, Current 3,970   3,970   $ 3,140
Third Party Product Manufacturer [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Accounts Payable, Current 3,100   $ 3,100   $ 2,300
Common Stock [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock Issued During Period, Shares, New Issues     3,600    
Stock Issued During Period, Value, New Issues     $ 4    
Service Agreement [Member] | Third Party Manufacturer [Member] | Common Stock [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Research and Development Expense     3,700    
Cash 1,700   $ 1,700    
Stock Issued During Period, Shares, New Issues     1,300    
Stock Issued During Period, Value, New Issues     $ 590    
Accounts Payable, Current $ 1,100   1,100    
Gain (Loss) Related to Litigation Settlement     $ 550